Cleared Traditional

K841703 - TDX REA LDH

K841703 is an FDA 510(k) clearance for TDX REA LDH, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code CFJ cleared through the Traditional 510(k) pathway after a 46-day FDA review.

K841703 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1984
Decision
46d
Days
Class 2
Risk

K841703 is an FDA 510(k) clearance for the TDX REA LDH. Classified as Nad Reduction/nadh Oxidation, Lactate Dehydrogenase (product code CFJ), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on June 8, 1984 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1440 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K841703

510(k) Number K841703 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 1984
Decision Date June 08, 1984
Days to Decision 46 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 88d · This submission: 46d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFJ Device Classification - Class 2, Special Controls

Product Code CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CFJ Nad Reduction/nadh Oxidation, Lactate Dehydrogenase

All 88
Devices cleared under the same product code (CFJ) and FDA review panel - the closest regulatory comparables to K841703.
LACTATE DEHYDROGENASE ASSAY KIT
K842507 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
LACTATE DENYDRO GENASE ASSAY KIT
K842244 · Diagnostic Chemicals, Ltd. (Usa) · Jul 1984
SIGMS PROCED. 228 UV LACTATE DEHYDRO
K841917 · Sigma Diagnostics, Inc. · Jun 1984
LDH-UV REAGENT SET
K841058 · Medical Specialties, Inc. · May 1984
KINETIC LDH, A< BLUE 610 METHOD
K840006 · American Monitor Corp. · Mar 1984
ASTRA SYSTEMS ENZYME MODULE LD-P
K832048 · Beckman Instruments, Inc. · Jul 1983